Guanidine

Guanidine

SCHEMBL6645147

N=C(N)N.O=S(=O)(O)OC1CC1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2

The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
GRIN1 Q05586 10/20 0.33
GRIN2B Q13224 10/20 0.33
GRIN2D O15399 2/20 0.33
GRIN2A Q12879 2/20 0.33
GRIN2C Q14957 2/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
BLM P54132 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NOS2 P35228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13976245 0.87
SCHEMBL16160748 0.87 CA2 (0.40) CA1CA2GRIN1GRIN2BGRIN2D
SCHEMBL17456540 0.85 CA2 (0.39) CA1CA2GRIN1GRIN2BGRIN2D
SCHEMBL8772824 0.81 CA1 (0.38) CA1CA2GRIN1GRIN2BGRIN2D
SCHEMBL17469919 0.77 GRIN1 (0.41) GRIN1GRIN2BGRIN2DGRIN2AGRIN2C
SCHEMBL3130594 0.77 CA2 (0.54) CA1CA2GRIN1GRIN2BGRIN2D
SCHEMBL18631967 0.76 GRIN1 (0.33) CA1CA2GRIN1GRIN2BGRIN2D
SCHEMBL5155129 0.75 CA1 (0.58) CA1CA2GRIN1GRIN2BCYP2C19
SCHEMBL11575485 0.75 CA1 (0.58) CA1CA2GRIN1GRIN2BCYP2C19
Ammonia Solution, Strong SCHEMBL27744923 0.73 CA1 (0.56) CA1CA2GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401836-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR THE PROPHYLAXIS AND TREATMENT OF HERPES VIRAL INFECTIONS SmithKline Beecham Corporation (US) 2004-03-31 EP disclosed
WO-2003000689-A1 IMIDAZO`1,2-A!PYRIDINE DERIVATIVES FOR THE PROPHYLAXIS AND TREATMENT OF HERPES VIRAL INFECTIONS SMITHKLINE BEECHAM CORPORATION (US) 2003-01-03 WO disclosed